Journal
RSC ADVANCES
Volume 7, Issue 4, Pages 2365-2372Publisher
ROYAL SOC CHEMISTRY
DOI: 10.1039/c6ra25938c
Keywords
-
Categories
Funding
- Shahid Beheshti University of Medical Sciences [7655]
Ask authors/readers for more resources
The ultrasensitive detection of human prostate metastatic cancer cells (Du-145) was investigated through a novel electrochemical cytosensor. The proposed biosensor was simultaneously developed via two approaches: multivalent identification and signal amplification. Herein, anti-CD166 monoclonal antibody-modified gold electrode was applied to capture and recognize target cells (Du-145). Also, a graphene (G)/gold nanoparticle (GNP)/horseradish peroxidase (HRP)-conjugated trastuzumab antibody (G/GNP/Ab-HRP) hybrid nanostructure was designed as a nanoprobe for accurate recognition of target cells and efficient amplification of enzymatic signals simultaneously. The performance of the cytosensor could be significantly improved by utilizing this novel signal-amplification strategy. The cytosensor described here exhibited an appropriate cell-capture ability, broad range of detection, and exceptional sensitivity with a low limit of detection (20 cells). The fabricated cytosensor showed high sensitivity and selectivity for detection of Du-145 cancer cells while keeping an extended linear range from 102 to 106 cells per ml, and a conveniently low limit of detection of 20 cells per ml. The extraordinary analytical performance of this cytosensor indicates that it has a great potential for the detection of cancer cells and cancer stem cells.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available